Profitelligence Profitelligence · Filing Ledger Search all insiders →

Insider Profile · SEC Form 4 Activity · Trailing 90 Days

Levy Richard S

Over the trailing 90 days, Levy Richard S (Director at MADRIGAL PHARMACEUTICALS, INC.) sold $2.9M of stock across 4 companies, per 20 SEC Form 4 transactions.

Role
Director
Companies
MDGL KNSA KOD TARA
Window
Trailing 90 days · 20 transactions · CIK 1454983
Net activity
−$2.9M ($0 bought · $2.9M sold)

By Company (Trailing 90 Days)

SymbolCompanyTxnsBoughtSoldNet
MDGLMADRIGAL PHARMACEUTICALS, INC.14$2.9M−$2.9M
KODKodiak Sciences Inc.1$0
TARAProtara Therapeutics, Inc.1$0
KNSAKiniksa Pharmaceuticals International, plc4$0

Transactions (20)

DateSymbolTypeSharesValueDescription
2026-06-30KODBuy17.7K$0Grant, award or other acquisition
2026-06-17MDGLBuy766$0Grant, award or other acquisition
2026-06-17MDGLBuy454$0Grant, award or other acquisition
2026-06-15TARABuy31.0K$0Grant, award or other acquisition
2026-05-29KNSABuy2.0K$0Grant, award or other acquisition
2026-05-29KNSABuy2.8K$0Exercise or conversion of derivative security
2026-05-29KNSABuy12.2K$0Grant, award or other acquisition
2026-05-29KNSASell2.8K$0Exercise or conversion of derivative security
2026-05-22MDGLSell320$163KOpen market or private sale
2026-05-22MDGLSell151$77KOpen market or private sale
2026-05-22MDGLSell610$312KOpen market or private sale
2026-05-22MDGLSell439$225KOpen market or private sale
2026-05-22MDGLSell40$21KOpen market or private sale
2026-05-22MDGLSell343$177KOpen market or private sale
2026-05-22MDGLSell657$339KOpen market or private sale
2026-05-22MDGLSell723$374KOpen market or private sale
2026-05-22MDGLSell1.5K$775KOpen market or private sale
2026-05-22MDGLSell40$20KOpen market or private sale
2026-05-22MDGLSell782$406KOpen market or private sale
2026-05-22MDGLSell80$42KOpen market or private sale

Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.

Follow Levy's next move

Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.

Start free